Entries by Sapienbio Staff
Human Patient Samples and Clinical Data webinar
The FABA-US Chapter is pleased to welcome you to our monthly webinar series and we are very much looking forward to your talk on November 16th, 2024 @ 9 PM | IST. Please find attached brochure to the event, that you may share with your network and post on your company website as well. Also […]
HRR testing including BRCA1/2 can guide therapy in Ovarian Cancer
Specific types of DNA damage, such as mismatches during replication, single- or double-strand DNA breaks, can result in the activation of specific signalling and repair cascades such as homologous recombination repair (HRR) in normal cells to repair the damage. However, deficiencies in these repair pathways result in the accumulation of DNA damage, genomic instability, and […]
Today is World Ovarian Cancer Day
World Ovarian Cancer Day is observed on May 8th each year, to raise awareness about Ovarian Cancer, its symptoms, risk factors, and the importance of early detection and personalized treatment. Ovarian cancer is one of the most common gynecological cancers that ranks third after cervical and uterine cancer with high incidence in Asian women (9.2 […]
Diagnostic methods for breast cancer used in India
Breast cancer can be diagnosed through multiple tests, including a mammogram, self-examination, ultrasound, MRI and biopsy. If the doctor finds an area of concern on a screening test (a mammogram), or if the patient has symptoms that could mean breast cancer, then more tests need to be done in order to diagnose whether it is […]
Sapien’s breast cancer database showcased @BioAsia2020, shortlisted by an expert selection committee for Startup Stage @ BioAsia 2020.
Sapien Biosciences team @ BioAsia 2020, at Stall # S14. Sapien was selected from the Startup Stage competition and awarded free exhibit space and delegate pass at BioAsia. Here we showcased several breast cancer patients’ tissue-derived in vitro models for testing new drugs and markers at Sapien. The deep database of […]
Panel discussion on Innovation at the Academia Industry Synergy Day at NIPER-Hyderabad
NIPER Hyderabad had a star-studded Academia-Industry Synergy day on 23rd Aug, 2018. I was asked to moderate apanel on Innovation and Entrepreneurship. I chose to focus on the aspect of driving innovation already at NIPER-H towards commercialization. Invited Dr. Ashutosh of NIPER to identify where the gaps are, and put them to a panel of seasoned people drawn from […]
Establishment of glioma patient derived 3D culters to evaluate the potency of drugs compared to 2D model
Attended Regional Young investigator meeting, Hyderabad (18th – 19th August, 2018) at University of Hyderabad. Sapien Biosciences presented importance of primary human patient cultures, especially spheroid (3D) for drug testing in Glioblastoma multiforme. We have identified molecules that demonstrated differential anti-cancer activity between 2D and 3D cultures in functional readouts including cancer stem cells.
Markup: HTML Tags and Formatting
Header one Header two Header three Header four Header five Header six This is default paragraph. Morbi sagittis sem quis lacinia faucibus, this is a text link orci ipsum gravida tortor, vel interdum mi sapien ut justo. Nulla varius consequat magna, id molestie ipsum volutpat quis. Suspendisse consectetur fringilla luctus. Fusce id mi diam, non […]
Recent Comments